Carcinoma, Intraductal, Noninfiltrating
"Carcinoma, Intraductal, Noninfiltrating" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A noninvasive (noninfiltrating) carcinoma of the breast characterized by a proliferation of malignant epithelial cells confined to the mammary ducts or lobules, without light-microscopy evidence of invasion through the basement membrane into the surrounding stroma.
| Descriptor ID |
D002285
|
| MeSH Number(s) |
C04.557.470.200.025.275 C04.557.470.200.240.187.250 C04.557.470.615.275
|
| Concept/Terms |
Carcinoma, Intraductal, Noninfiltrating- Carcinoma, Intraductal, Noninfiltrating
- Carcinoma, Intraductal
- Carcinomas, Intraductal
- Intraductal Carcinoma
- Intraductal Carcinomas
- DCIS
- Ductal Carcinoma In Situ
- Intraductal Carcinoma, Noninfiltrating
- Carcinoma, Noninfiltrating Intraductal
- Carcinomas, Noninfiltrating Intraductal
- Intraductal Carcinomas, Noninfiltrating
- Noninfiltrating Intraductal Carcinoma
- Noninfiltrating Intraductal Carcinomas
Atypical Ductal Hyperplasia- Atypical Ductal Hyperplasia
- Atypical Ductal Hyperplasias
- Ductal Hyperplasia, Atypical
- Ductal Hyperplasias, Atypical
- Hyperplasia, Atypical Ductal
- Hyperplasias, Atypical Ductal
|
Below are MeSH descriptors whose meaning is more general than "Carcinoma, Intraductal, Noninfiltrating".
- Diseases [C]
- Neoplasms [C04]
- Neoplasms by Histologic Type [C04.557]
- Neoplasms, Glandular and Epithelial [C04.557.470]
- Carcinoma [C04.557.470.200]
- Adenocarcinoma [C04.557.470.200.025]
- Carcinoma, Intraductal, Noninfiltrating [C04.557.470.200.025.275]
- Carcinoma in Situ [C04.557.470.200.240]
- Breast Carcinoma In Situ [C04.557.470.200.240.187]
- Carcinoma, Intraductal, Noninfiltrating [C04.557.470.200.240.187.250]
- Neoplasms, Ductal, Lobular, and Medullary [C04.557.470.615]
- Carcinoma, Intraductal, Noninfiltrating [C04.557.470.615.275]
Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Intraductal, Noninfiltrating".
This graph shows the total number of publications written about "Carcinoma, Intraductal, Noninfiltrating" by people in this website by year, and whether "Carcinoma, Intraductal, Noninfiltrating" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 1 | 1 | 2 |
| 2002 | 1 | 1 | 2 |
| 2003 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2010 | 2 | 0 | 2 |
| 2011 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 0 | 1 | 1 |
| 2015 | 3 | 0 | 3 |
| 2017 | 1 | 1 | 2 |
| 2018 | 0 | 1 | 1 |
| 2021 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Carcinoma, Intraductal, Noninfiltrating" by people in Profiles.
-
No Treatment Versus Partial Mastectomy Plus Radiation for Ductal Carcinoma In Situ. Ann Surg Oncol. 2022 Jan; 29(1):39-41.
-
Prognostic factors for residual occult disease in shave margins during partial mastectomy. Breast Cancer Res Treat. 2021 Sep; 189(2):471-481.
-
Variability in the Management Recommendations Given for High-risk Breast Lesions Detected on Image-guided Core Needle Biopsy at U.S. Academic Institutions. Curr Probl Diagn Radiol. 2019 Sep - Oct; 48(5):462-466.
-
Recommendations for Pathologic Evaluation of Reduction Mammoplasty Specimens: A Prospective Study With Systematic Tissue Sampling. Arch Pathol Lab Med. 2017 Nov; 141(11):1523-1528.
-
Association of Radiotherapy Boost for Ductal Carcinoma In Situ With Local Control After Whole-Breast Radiotherapy. JAMA Oncol. 2017 Aug 01; 3(8):1060-1068.
-
Surgical margin reporting in breast conserving surgery: Does compliance with guidelines affect re-excision and mastectomy rates? Breast. 2015 Oct; 24(5):618-22.
-
AnMed Health Compliance Study--Adjuvant Radiation Therapy Following Breast Conserving Surgery. J S C Med Assoc. 2015 Jun; 111(2):64-5.
-
Perceptions of Contralateral Breast Cancer Risk: A Prospective, Longitudinal Study. Ann Surg Oncol. 2015 Nov; 22(12):3846-52.
-
A framework for evaluating diagnostic discordance in pathology discovered during research studies. Arch Pathol Lab Med. 2014 Jul; 138(7):955-61.
-
Prospective multicenter trial evaluating balloon-catheter partial-breast irradiation for ductal carcinoma in situ. Int J Radiat Oncol Biol Phys. 2013 Nov 01; 87(3):494-8.